Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

SPRY holding history

ARS Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SPRY overviewAll 13F holders of SPRYFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of SPRY by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−11,873−100.0%Sold outHolders
Q1 202611,873$95.3K<0.1%−14,654−55.2%ReducedHolders
Q4 202526,527$309.0K<0.1%−7,692−22.5%ReducedHolders
Q3 202534,219$343.9K<0.1%−23,230−40.4%ReducedHolders
Q2 202557,449$1.00M<0.1%+23,652+70.0%AddedHolders
Q1 202533,797$425.2K<0.1%−42,935−56.0%ReducedHolders
Q4 202476,732$809.5K<0.1%−3,816−4.7%ReducedHolders
Q3 202480,548$1.17M<0.1%+12,315+18.0%AddedHolders
Q2 202468,233$580.7K<0.1%+30,056+78.7%AddedHolders
Q1 202438,177$390.2K<0.1%+38,177NewHolders
Q2 20230$00.0%−24,302−100.0%Sold outHolders
Q1 202324,302$158.2K<0.1%−19,396−44.4%ReducedHolders
Q4 202243,698$372.7K<0.1%+14,409+49.2%AddedHolders
Q3 202229,289$155.0K<0.1%−62,834−68.2%ReducedHolders
Q2 202292,123$391.0K<0.1%−95,199−50.8%ReducedHolders
Q1 2022187,322$658.0K<0.1%−62,694−25.1%ReducedHolders
Q4 2021250,016$1.67M<0.1%−564−0.2%ReducedHolders
Q3 2021250,580$2.50M<0.1%+40,453+19.3%AddedHolders
Q2 2021210,127$6.49M<0.1%+4,714+2.3%AddedHolders
Q1 2021205,413$8.96M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.